NEC aims to develop cancer drugs using artificial intelligence

NEC Corp. said it will develop cancer drugs using artificial intelligence, aiming to put new vaccines using peptides into practical use within the next eight years as key substances in next generation immunotherapy.
http://www.japantimes.co.jp/news/2016/12/19/business/tech/nec-aims-develop-cancer-drugs-using-artificial-intelligence/#.WFkWr1MrLIU

AUDIENCES

Caregivers
Friends and Family
General Public
Medical Profession
Patients
Survivors

SUBJECTS

Post Surgical

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino